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DObjective:Mitral valve repair for functional mitral regurgitation is common. Concomitant tricuspid valve repair
for associated functional tricuspid regurgitation has gained favor. Controversy exists regarding annuloplasty
sizing for tricuspid valve repair.
Methods: Patients with heart failure having functional mitral regurgitation at the University of Michigan and
undergoing mitral valve repair and tricuspid valve repair using identical sized annuloplasty rings between April
2007 and January 2012 were identified. Demographic and clinical records were retrospectively reviewed.
Institutional review board approval was obtained for this study.
Results: Fifty-three patients met inclusion criteria. Mean age was 65 1.7 years. Preoperative New York Heart
Association class was III or IV in 81% (43) and mean left ventricular ejection fraction was 33%  2.2%. All
patients had moderate or greater mitral regurgitation preoperatively and moderate or severe tricuspid
regurgitation or a preoperative tricuspid annulus diameter greater than 40 mm. There was no 30-day mortality.
Mean immediate postoperative tricuspid valve gradient was 1.75 0.12 mmHg and was 2.3 0.19 mmHg at 4
weeks. Four weeks postoperatively 88% (42/48) of patients had tricuspid regurgitation considered to be mild or
less. There was no significant decline in right ventricular function by echocardiography over this time period.
Conclusions: Functional tricuspid regurgitation can be repaired using an undersized rigid annuloplasty ring.
Our data suggest that an identical sizing strategy can be used for tricuspid valve repair, as was used for mitral
valve repair, without development of tricuspid stenosis or negative effect on right ventricular function. This
method seems to prevent recurrence of significant tricuspid regurgitation. The technique we describe provides
effective and reproducible results. (J Thorac Cardiovasc Surg 2014;147:611-4)Functional tricuspid regurgitation (TR) is an important
clinical condition for which surgical repair is being increas-
ingly applied.1,2 An estimated 1.6 million patients in the
United States have moderate or greater TR.3 Functional
TR is usually a secondary result of left-sided heart failure.4
Typically associated with myocardial or valvular dysfunc-
tion, right ventricular (RV) enlargement and asymmetric
tricuspid annular dilation lead to TR. Patients with un-
treated TR can have significant clinical symptoms including
fatigue, decreased exercise tolerance, edema, and ascites.1
TR has been shown to increase mortality independent of
left ventricular ejection fraction, RV size, and RV function.5
Of special interest is the development of significant TR
years after mitral valve (MV) surgery. A growing body of
literature supports the notion that ‘‘benign neglect’’ of TRe University of Michigan, Ann Arbor, Mich.
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The Journal of Thoracic and Caat the time of MV surgery (especially in the presence of
tricuspid annular dilation) can no longer be considered
acceptable.2,5
Additionally, reoperations for recurrent TR are
associated with high surgical risk (up to 37% in-hospital
mortality).6,7 Because of this higher risk, more aggressive
treatment of TR at the time of initial surgery may be
prudent. This is especially important inasmuch as TR
does not reliably resolve, and frequently progressively
worsens, even after successful MV surgery.6,8,9
If present at the time of MV surgery, functional TR can
usually be treated with ring annuloplasty.8 Successful
tricuspid valve (TV) repair results in a significant improve-
ment in recurrent TR, RV function, event-free survival, and
functional outcome.2,7 The American College of
Cardiology/American Heart Association 2006 Practice
Guidelines for the surgical management of patients with
TR give a class I indication for TV repair in any patient
with severe TR undergoing MV surgery.10 Current Euro-
pean Society of Cardiology 2007 guidelines recommend
(class IIa) tricuspid repair for moderate TR with a dilated
(>40 mm) annulus in a patient undergoing left-sided
surgery.11
Significant advances have been made in disease-specific
repair strategies for mitral regurgitation, but less is knownrdiovascular Surgery c Volume 147, Number 2 611
Abbreviations and Acronyms
CI ¼ confidence interval
MV ¼ mitral valve
RV ¼ right ventricular
TR ¼ tricuspid regurgitation
TS ¼ tricuspid stenosis
TV ¼ tricuspid valve
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Dabout similar repair strategies for concomitant TR. Many
would agree that rigid ring TV annuloplasty offers a better
long-term solution than a nonring approach.8,12,13 In
a study of 790 patients undergoing TV repair via 4
different methods, McCarthy and associates8 found that
recurrent TR became more severe faster and was more
prevalent after a De Vega compared with a ring
annuloplasty. Others have corroborated the finding of late
recurrence of significant TR after De Vega, including
a prospective randomized trial by Rivera and associates12
comparing De Vega with the Carpentier-Edwards ring.
Controversy exists regarding size selection for TV
annuloplasty.8,13-15 Methods of sizing have varied. Some
have warned against undersizing the TV annuloplasty to
avoid a theoretical risk of tricuspid stenosis (TS) or RV
failure from loss of ‘‘pop-off,’’ whereas others have
suggested complex methods such as using a ratio of 2.43:1
between the anteroposterior and septal segments as a guide.15
This study reviewed midterm outcomes of patients who
had both mitral regurgitation and TR, who underwent MV
repair with a rigid complete annuloplasty ring, and who
simultaneously underwent TV repair using a simple
strategy of identical sized TV annuloplasty ring.PATIENTS AND METHODS
Patients
From April 2007 to January 2012, all patients with congestive heart
failure at the University of Michigan Medical Center undergoing MV
and TV repair using identical sized annuloplasty rings (either 26 or 28
mm) were identified. Patients with endocarditis, rheumatic valve disease,
or organic disease of the TV leaflets, including congenital anomalies,
were excluded. Patient demographics, clinical characteristics, echocardio-
grams, operative reports, hospital records, and clinic notes were collected
from the prospective University ofMichigan Cardiovascular Databank, and
a retrospective analysis was performed. Institutional review board approval
was obtained for this study.
Methods
Annuloplasty ring type was determined by surgeon preference at the
time of operation. In general, complete rigid rings were used in the mitral
position. The TV ring size was matched to the MVannuloplasty ring size.
Tricuspid rings were all rigid remodeling rings.
Whenwewere collecting data from echocardiogram reports, descriptors
such as ‘‘mild to moderate’’ or ‘‘moderate to severe’’ were recorded in our
database as the greater of the 2 values (ie, ‘‘mild to moderate mitral regur-
gitation’’ was recorded as moderate). In cases in which echocardiogram612 The Journal of Thoracic and Cardiovascular Surgreports documented regurgitation as ‘‘none,’’ ‘‘1þ,’’ ‘‘2þ,’’ ‘‘3þ,’’ or
‘‘4þ,’’ these were reported as ‘‘none,’’ ‘‘trace,’’ ‘‘mild,’’ ‘‘moderate,’’ or
‘‘severe’’ in our database, respectively.
Descriptive statistics were used to describe the study population.
Tricuspid gradient is reported as mean  standard error of means. Decline
in RV function over time was evaluated for patients who had preoperative
and 4-week postoperative echocardiograms available that specifically
reported on RV function. A 70% confidence interval (CI) for the proportion
of patients with increased RV dysfunction 4 weeks postoperatively was
calculated.RESULTS
Fifty-three patients underwent combined MV and TV
repair using identical sized rings between April 2007 and
January 2012. Patient characteristics are summarized in
Table 1. The mean age was 65  1.7 years and 43% were
male. Preoperative New York Heart Association functional
class was III or IV in 81% (n ¼ 43) and mean left
ventricular ejection fraction was 33% 2.2%. All patients
had moderate or greater mitral regurgitation before surgery.
All patients also had preoperative moderate or severe TR or
a preoperative tricuspid annulus diameter greater than 40
mm. Concomitant procedures included coronary artery
bypass grafting (n ¼ 5), the maze procedure (n ¼ 24), the
Acorn procedure (n ¼ 2), and atrial septal defect/patent
foramen ovale closure (n ¼ 7). Sixteen were reoperations.
The average cardiopulmonary bypass and crossclamp times
were 90  2.2 minutes and 71  2.6 minutes, respectively.
Four-week follow-up data were available for 48 (91%)
patients and intermediate-term data were available in
9 (17%). There was no 30-day mortality. There were 3 pa-
tients who required prolonged ventilatory support, 1 stroke,
and 4 late deaths. Preoperative and postoperative TR, TV
gradient, and RV function are reported in Table 2. The
mean immediate postoperative TV gradient was
1.75  0.12 mm Hg and at 4 weeks’ follow-up it was
2.3  0.18 mm Hg. Four weeks postoperatively, 88%
(42/48) of patients had TR considered to be mild or less
on a scale of ‘‘none,’’ ‘‘trace,’’ ‘‘mild,’’ ‘‘moderate,’’ or ‘‘se-
vere.’’ At 4 weeks, 10% (5/48) had moderate TR (compared
with 36% preoperatively) and 2% (1/48) had severe TR
(compared with 34% preoperatively). RV function was
specifically evaluated by echocardiography preoperatively
and 4 weeks postoperatively in 30 patients. A 70% CI
was calculated around the percentage of patients whose
RV function worsened during this time frame. Of the 30
patients, 30% showed worsening of their RV function
(CI 70%, 21, 41). In addition, 33% (CI 70%, 24, 44)
showed improvement in their RV function at the time of
4-week postoperative echocardiogram. No patient had any
clinical evidence of RV failure at 4 weeks of follow-up.DISCUSSION
Surgery of the TV for significant TR should occur at the
time of MV surgery. Most now agree that surgical treatmentery c February 2014
TABLE 1. Patient characteristics
Characteristic Value (%), n ¼ 53
Age at operation, y 65 (41-88)
Male (%) 23 (43)
Preoperative smoking (%) 12 (23)
Preoperative comorbidity
COPD 6 (11)
Renal failure 8 (15)
Creatinine 1.4  0.17
Diabetes 16 (30)
TIA 4 (7.5)
CVA 2 (3.8)
Preoperative EF 33  2.2
NYHA class (%)
I 0 (0)
II 10 (18.9)
III 39 (73.6)
IV 4 (7.5)
Redo operation (%) 16 (30)
Concurrent procedures (%)
Maze 24 (45)
CABG 5 (9.4)
Acorn 2 (3.8)
PFO/ASD closure 7 (13)
Mitral/tricuspid ring size used (mm)
26 (%) 45 (85)
28 (%) 8 (15)
COPD, Chronic obstructive pulmonary disease; TIA, transient ischemic attack;
CVA, cerebrovascular accident; EF, ejection fraction; NYHA, New York Heart
Association; CABG, coronary artery bypass grafting; PFO, patient foramen ovale;
ASD, atrial septal defect.
Huffman et al Acquired Cardiovascular Disease
A
C
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in RV function or secondary amelioration of TR. Further,
reoperation for TV repair, if offered at all, carries high
surgical risk.
Benedetto and colleagues2 showed significant reverse RV
remodeling among patients treated with concomitant MVTABLE 2. Changes in RV function, TR, and TV gradient over time
Variable Baseline
Four-week
follow-up
Intermediate-term
follow-up
(mean, 12.9 mo;
range, 2-33 mo)
RV dysfunction n ¼ 53 (%) n ¼ 40 (%) n ¼ 7 (%)
None 36 (68) 18 (45) 2 (28.6)
Mild 8 (15) 9 (23) 1 (14.3)
Moderate 4 (8) 8 (20) 2 (28.6)
Severe 5 (9) 4 (10) 2 (28.6)
TR n ¼ 53 (%) n ¼ 48 (%) n ¼ 9 (%)
Mild or better 16 (30) 42 (88) 8 (89)
Moderate 19 (36) 5 (10) 0 (0)
Severe 18 (34) 1 (2) 1 (11)
TV gradient Immediately
postop; n ¼ 53
n ¼ 43 n ¼ 5
1.75  0.12 2.3  0.18 2.8  0.74
RV, Right ventricle; TR, tricuspid regurgitation; TV, tricuspid valve.
The Journal of Thoracic and Carepair/TV repair. They also demonstrated a significantly
lower grade of TR and a significant improvement in
functional class among the patients who underwent TV
repair at the time of MV repair at 1 year’s follow-up.
Any patient with greater than 2þ TR or a tricuspid
annular diameter 40 mm or greater in any echocardio-
graphic view should be considered for TV repair.16 The
best time to evaluate for TR is during a preoperative
workup, before the patient reaches the operating room for
the concomitant procedure. Under general anesthesia,
even severe TR may appear mild. The TV annulus should
also be measured during the preoperative echocardiogram
along with RA and RV size and function.
The primary goal in surgical correction of functional TR
is to reduce the annular size to achieve leaflet coaptation.
The application of a rigid ring has been shown to offer the
most durability over time in multiple series compared
with flexible bands or plication annuloplasty techniques.8
Rigid annuloplasty should be the preferred surgical
approach for significant TR if the leaflets are spared from
the disease process.
Ring Sizing in Functional TR
Tricuspid sizing based on the septal leaflet is now
believed to be an inaccurate method to determine tricuspid
annular size in functional TR. The tricuspid annulus is
dynamic and may change by as much as 19% in circumfer-
ence during systole with a 30% reduction in annular
area.17,18 Fukuda and colleagues18 have demonstrated that
the normal 3-dimensional annulus becomes more planar
in patients with functional TR.
Further apprehension exists regarding size selection for
the tricuspid annuloplasty because of the suggestion that
undersizing the TV annuloplasty may result in subsequent
TS. We1 have previously reported that tricuspid annulo-
plasty with an undersized (26 or 28 mm) ring does not result
in TS. Our results in this study support that conclusion and
showed a peak gradient of 2.8  0.74 at intermediate-term
follow-up.
Other authors have warned against aggressively treating
TR for fear of worsening RV function.13 In our study there
was no significant worsening of RV function, with most
patients having normal to only moderately decreased
function at 4 weeks, in line with their preoperative right
heart function. Further, no significant recurrent TR was
seen at 4 weeks’ follow-up with this approach.
CONCLUSIONS
We reviewed patients who underwent MV repair with
a rigid complete annuloplasty ring and who simulta-
neously underwent TV repair with use of the identical
sized TV annuloplasty ring (26 or 28 mm). Our data
suggest that an identical sized ring strategy can be used
for TV repair as was used for MV repair, withoutrdiovascular Surgery c Volume 147, Number 2 613
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tion. Further, this approach seems to prevent early recur-
rence of significant TR.
Despite the American College of Cardiology/American
Heart Association and European Society of Cardiology
guidelines, which support surgical repair of TR at the
time of MV surgery in many patients, TV repair is under-
used. The current surgical volume of TV repair with or
without concomitant MV surgery as quantified in the
Society of Thoracic Surgeons National Cardiac Database
averages between 4000 and 4500 operations per year
(2005-2007).1 This represents only approximately one tenth
of the greater than 50,000 MVoperations performed yearly
in the United States.19
Given the adverse consequences of allowing TR to
progress in severity (such as worsening symptoms of right
heart failure), it is logical that earlier intervention for TR,
especially in the presence of right atrial and RV enlarge-
ment, would be beneficial. There are few data that can be
used to specifically address this important question. A
randomized trial comparing benign neglect of TR versus
earlier intervention may be required to gain further insight
and is presently being entertained by the National Heart,
Lung, and Blood Institute.
Functional TR can be reliably repaired, much like
functional mitral regurgitation, using an undersized annulo-
plasty ring. Using the identical sized rigid annuloplasty ring
for concomitant MV repair/TV repair offers a relatively
simple, safe, and effective strategy for treatment of
functional mitral regurgitation and TR. The technique we
describe is a simple and reliable method that provides
effective and reproducible results. Longer follow-up and
larger sample size are needed to evaluate the stability of
these early results.
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